SIBN

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About SI-BONE Inc

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a source of pain in 15% to 30% of chronic low back pain. The iFuse Implant™, commercially available since 2009, is the only SI joint fusion device supported by multiple prospective clinical studies, including two randomized controlled trials, showing improved pain, patient function and quality of life resulting from treatment. There are over 90 peer-reviewed publications demonstrating the safety, durable effectiveness, and biomechanical and economic benefits unique to the iFuse Implant (www.si-bone.com/results). This body of evidence has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
CEO
Jeffrey Dunn
Employees
295
Headquarters

471 El Camino Real Ste 101
Santa Clara, California 95050-4482
Phone: 14082070700
si-bone.com

News

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 | SIBN Stock News
Apr 15, 2024 20:09pm

SI-BONE, Inc. (SIBN) will report its first-quarter 2024 financial results on May 6, 2024. The company focuses on musculoskeletal disorders of the sacropelvic anatomy. The conference call will be held at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors can register to listen to the call via a provided link. The webcast will be available on the company''s website for replay for at least 90 days.


Source:Stock Titan
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
Apr 15, 2024 20:09pm

SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May 6, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.


Source:GlobeNewswire
Si-Bone executive sells over $65k in company stock
Apr 05, 2024 00:03am

https://www.investing.com/news/company-news/sibone-executive-sells-over-65k-in-company-stock-93CH-3366782


Source:Investing.com
Si-Bone CFO sells over $37k in company stock
Apr 05, 2024 00:00am

https://www.investing.com/news/company-news/sibone-cfo-sells-over-37k-in-company-stock-93CH-3366781


Source:Investing.com
Si-Bone executive sells over $56,000 in company stock
Mar 14, 2024 21:49pm

https://www.investing.com/news/stock-market-news/sibone-executive-sells-over-56000-in-company-stock-93CH-3338991


Source:Investing.com
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
Mar 04, 2024 21:09pm

SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami. Management will be hosting a fireside chat on Tuesday, March 12, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.


Source:GlobeNewswire
Cantor Fitzgerald maintains $25 target on SI-BONE shares
Feb 27, 2024 19:27pm

https://www.investing.com/news/stock-market-news/cantor-fitzgerald-maintains-25-target-on-sibone-shares-93CH-3317196


Source:Investing.com
SI-BONE Inc (SIBN) Reports Record Revenue Growth in Q4 and Full Year 2023
Feb 26, 2024 21:34pm

SI-BONE Inc (SIBN) Reports Record Revenue Growth in Q4 and Full Year 2023


Source:GuruFocus
Recap: SI-BONE Q4 Earnings
Feb 26, 2024 21:25pm

SI-BONE (NASDAQ: SIBN ) reported its Q4 earnings results on Monday, February 26, 2024 at 04:09 PM. Here''s what investors need to know about the announcement. Earnings SI-BONE beat estimated earnings by 4.0%, reporting an EPS of $-0.27 versus an … Full story available on Benzinga.com


Source:Benzinga
SI-BONE GAAP EPS of -$0.27 in-line, revenue of $38.9M beats by $0.31M
Feb 26, 2024 21:22pm

No summary available.


Source:Seeking Alpha